• Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(4)

    12 days ago - By Precision Biosciences

    DURHAM, N.C. --May 12, 2022- Precision BioSciences, Inc. , a clinical stage gene editing company developing ARCUS ® -based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on May 6, 2022 , the Compensation Committee of Precision's
    Read more ...